AOUSTIA PHARMACEUTICALS

PRODUCTS

Aoustia has worked towards improving the lives of patients globally. In the pursuit of this mission, Aoustia has focused on building a global Innovative/Specialty, Generics and OTC business in the therapy areas of Circulatory, Respiratory and Oncology. It also has strong regional/country-specific presence in other therapeutic areas like diabetes, cardiovascular and oral contraceptives.

​Research & Development
Innovation is at the core of everything we do. It has been our endeavor to continuously innovate to improve lives of patients globally. In this quest, Aoustia is committed to address needs in the therapy areas of circulatory, oncology and respiratory. Today we have a strong pipeline of specialty products and innovative molecules. 

​Focus on high quality formulations
Aoustia has focused on developing branded and generic formulations for over 5 decades positively impacting lives globally. In branded formulations, we are focused on developing innovative products for markets such as Belgium, India, Russia & CIS,  Belarus and Africa. The focus has been to develop products across respiratory, cardio-metabolic therapy areas for the patients. In generics, we are developing high quality affordable products for markets such as US and Europe.

Active Pharmaceutical Ingredients
Aoustia's API business, an independent subsidiary called Aoustia Pharms , manufactures and supplies over 130 molecules to more than 700 customers. Aoustia partners with leading global generic companies, by supporting partnerships through advanced process chemistry skills and innovative intellectual property. Our API business spans over 65 countries. Aoustia is a market leader for many API products in semi-regulated markets and has also established a leadership position with its first-to-file offerings in regulated markets.

Services

Aoustia, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 5+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.